Kliniska studier för Lupus i Oklahoma
8 studier för Lupus söker deltagare vid platser i Oklahoma.
Städer i Oklahoma
Officiell studietext (engelska)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50262, Oklahoma City
RekryterarFas 3
Ålder 16 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Oklahoma Medical Research Foundation, Oklahoma City
RekryterarFas 2
Ålder 18 till 74 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07409181A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Oklahoma City
- Research Site, Oklahoma City
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07430306A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
- Oklahoma Medical Research Foundation, Oklahoma City
RekryterarFas 4
Ålder 18 till 75 · Alla kön · Uppdaterad 9 sep. 2026 · NCT06875960A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Oklahoma Medical Research Foundation, Oklahoma City
RekryterarObservationsstudie
Ålder 16 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT07175285Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- Oklahoma Medical Research Foundation, Oklahoma City
RekryterarFas 3
Ålder 55 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT05799378A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Oklahoma, Oklahoma City
RekryterarFas 1
Ålder 12 till 70 · Alla kön · Uppdaterad 22 maj 2026 · NCT06308978Safety of the Herpes Zoster Subunit Vaccine in Lupus
- Oklahoma Medical Research Foundation, Oklahoma City
RekryterarFas 4
Ålder 18 till 90 · Alla kön · Uppdaterad 26 dec. 2025 · NCT05559671Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.